MedTech Integrates 2020 Track 2
TREATMENT
From pills to prosthetics, 3D printing seems to be taking healthcare by storm. Could this be the ultimate personalised healthcare? Are implantable medical devices invasive or ingenious? With more stringent regulation around apps and wearables, can we now trust our healthtech?
Welcome and opening remarks
Martino Picardo, Chairman, Discovery Park
An interview with Ben Newton
Global Head of Oncology Solutions GE Healthcare
Interview conducted by Martino Picardo, Chairman, Discovery Park
Seeing (and enhancing) life in 3D
From pills to prosthetics, 3D printing seems to be taking healthcare by storm. Are we really going to see a printer in every pharmacy or hospital?
FACILITATED BY
MIKE HANNAY | Managing Director Medical Technologies | Innovation Facility
PANELLISTS INCLUDE
DAN CLARK | Head of Clinical Engineering | Nottingham University Hospital NHS Trust
ASHLEY STRATTON-POWELL | Technical Lead for Orthopaedics, Medicines and Healthcare Products | MHRA
RUSSELL HARRIS | Director of the Future Manufacturing Processes Research Group, School of Mechanical Engineering | University of Leeds
HENRY PINCHBECK | Chief Executive Officer | 3D Lifeprints
Invasive or ingenious
Could implantables be the key to managing chronic diseases?
FACILITATED BY
PARI DATTA | Senior Innovation Consultant | Cambridge Design Partnership
PANELLISTS INCLUDE
MIKE KARIM | Chief Executive Officer | Oxford Endovascular
CATHERINE DAVIDSON | Head of Business Development – Life Science | MIDAS
RUSS BRADFORD | Co-Founder | Parkinson’s Concierge
Rules are rules
With the regulations around wearables and health apps getting more stringent, are we going to get more trust in tech?
FACILITATED BY
JAMES FRY | Partner | Mills & Reeve
PANELLISTS INCLUDE
MARK CAMPBELL | Independent Healthtech Consultant
SAM SHAH | Clinical Director | The Ivory Clinic
ARUN PAREKKAT | Digital Analytics Consultant
ROBERTO LIDDI | Senior Vice President, Quality Regulatory and IG Compliance | Sensyne Health
MICHAEL KIPPING | Innovation Lead – Biomedical Catalyst, Health Sector Team | Innovate UK
TINA WILSON | VP, Client Partner – Global Health and Life Sciences | Astound Commerce
Horses for courses
Which investors are right for you and your company? Medtech is a broad church in terms of routes to market, potential business model options and financing requirements. Your financing strategy goes hand-in-hand with your business strategy. What type of financing and which investors at what stage is key to making it all work.
FACILITATED BY
LOUISE JOPLING | Commercial Director | Eastern Academic Health Science Network
PANELLISTS INCLUDE
REBECCA TODD | Investment Director | Longwall Venture Partners
CHRIS EVANS | Founder | Little Journey
JASON MELLAD | Chief Executive Officer | Start Codon
SUNIL SHAH | Managing Partner, Therapeutics | o2h Ventures
WILL BROOKS | Investment Director | Downing
JIM STEEL | Head of Healthcare & Life Sciences Investment Banking team | Peel Hunt LLP
The Principles of Successful NHS Market Access
Demonstration of the clear benefits of New Technologies to Patients, Providers of Care, Payers of Care and Optimising selling pricing whilst ensuring the technology reached the patients who need it
FACILITATED BY
MICHAEL BRANAGAN-HARRIS | Chief Executive Officer | Device Access UK Ltd
PANELLISTS INCLUDE
RICHARD MOSS | Director and General Manager, UK & Ireland | SI-Bone
JOHN WEST | Director | Pellere Health
AMANDA HAYHURST | Founder | Gloucester Road Communications
CHRIS BECKLEY | Market Access & Public Affairs Director | Chiesi Ltd
Virtual drinks reception sponsored by UKRI Innovate UK
Ian Campbell, Interim Chief Executive, Innovate UK